Immunotherapy in Nonendemic Nasopharyngeal Carcinoma: Real-World Data from Two Nonendemic Regions.

Panagiota Economopoulou Anastasios Pantazopoulos Aris SpathisIoannis KotsantisAnastasios KyriazoglouGeorge KavourakisRoubini ZakopoulouIoannis ChatzidakisMaria AnastasiouMaria PrevezanouCarlo ResteghiniLisa LicitraCristiana BergaminiElena ColomboFrancesca CaspaniNerina Denaro Stefania VecchioPierluigi BonomoMaria Cossu RoccaFederica BertoliniDaris FerrariAmanda PsyrriPaolo Bossi

Published in: Cells (2021)

among 46 patients with R/M NPC treated with immunotherapy in two nonendemic regions, ORR was 26.2% and durable responses were observed. Low disease burden could serve as a biomarker for response to ICI.

Keyphrases

electronic health record
big data
risk factors
machine learning
deep learning